Instilling Confidence Here at Este Training Academy, we are dedicated to instilling confidence and ambition within all our graduates
What Ongoing Research May Clarify A PL 14736 trial (PL 14736 is the pharmaceutical-grade formulation of BPC-157 developed for clinical investigation) was listed on ClinicalTrials.gov for inflammatory bowel disease, though results have not been published as of May 2026 15
2K followers 500+ connections Sign in to view Maximes full profile or New to LinkedIn
The majority of musculoskeletal animal studies dose BPC-157 once daily, with regimens ranging from a single dose to daily administration for 7, 14, 28, or up to 90 days, depending on the injury model and outcome measures [20, 24, 26, 38, 60, 61]
DSIP has been studied in humans since the early 1980s, with multiple double-blind placebo-controlled trials